AIM ImmunoTech Inc.
AIM
$0.29
-$0.02-5.79%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.03% | 11.24% | -52.18% | 36.31% | 52.55% |
| Total Depreciation and Amortization | -32.81% | -14.29% | -9.84% | 0.00% | 10.34% |
| Total Amortization of Deferred Charges | 334.78% | 281.58% | -39.59% | -12.33% | -- |
| Total Other Non-Cash Items | 324.78% | 126.67% | -63.57% | 311.43% | -31.56% |
| Change in Net Operating Assets | -108.83% | -704.16% | 134.49% | 3.13% | -32.04% |
| Cash from Operations | 49.79% | -63.31% | 49.10% | 50.97% | 59.47% |
| Capital Expenditure | -- | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.56% | -15.91% | -8.72% | 668.35% | 1,466.79% |
| Cash from Investing | -102.56% | -11.38% | -8.72% | 668.35% | 1,830.84% |
| Total Debt Issued | -- | -100.00% | 287.97% | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 172,800.00% | -80.08% | 100.61% | -78.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 450.64% | -- | -- | -- | -- |
| Cash from Financing | 162.20% | 4,756.93% | -85.46% | -76.67% | 605.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.83% | 170.90% | -262.93% | 62.55% | 108.00% |